McKee Amy E
SEC Form 4 insider trading activity
McKee Amy E has filed 7 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 2, 2026.
On the most recent filing, McKee Amy E is listed as Director at BIOCRYST PHARMACEUTICALS INC. Inside the rolling window, McKee Amy E reported no open-market purchases and 1 open-market sale totaling $100K in BCRX.
Companies traded
Other insiders at BCRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$100K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has McKee Amy E made?
McKee Amy E has filed 7 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does McKee Amy E trade?
McKee Amy E has filed SEC Form 4 disclosures for 1 company, including BCRX.
When was McKee Amy E's most recent SEC Form 4 filing?
McKee Amy E's most recent SEC Form 4 filing on Tracefour is dated Sep 2, 2026.
What is McKee Amy E's total buy and sell value in the current window?
Inside the rolling retention window, McKee Amy E bought $0 and sold $100K based on SEC Form 4 filings.
What was McKee Amy E's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 11,180 BCRX shares on 2026-05-18, worth $100K, per SEC Form 4 filings.